Trevi Therapeutics, Inc. (TRVI) stock
TRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.51+0.22 (+1.66%)
Close on Nov 17, 2026Market cap $1.92BP/E –Yield –
Trevi Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Trevi Therapeutics's price to book ratio was 6.6× on Nov 11, 2026, against 8.9× a year earlier. Over the last 5 years it ranged from 0.8× to 13.9×, with a median of 3.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.6× | −1.9 |
| 2025 | Dec 31, 2025 | 8.5× | +3.2 |
| 2024 | Dec 31, 2024 | 5.3× | +4.3 |
| 2023 | Dec 29, 2023 | 1.0× | −0.1 |
| 2022 | Dec 30, 2022 | 1.0× | −0.3 |
| 2021 | Dec 31, 2021 | 1.3× | +0.0 |
| 2020 | Dec 31, 2020 | 1.2× | +0.1 |
| 2019 | Dec 31, 2019 | 1.1× | – |
See a number that looks wrong?